Form 4: Confluent Director Sells Shares After Option Exercise
Insider Transaction Report
Confluent Director Alyssa Henry executed a pre-planned sale of 62,500 Class A shares at approximately $30.00 per share after converting Class B shares and exercising stock options.
Summary
- Alyssa Henry, a Director of Confluent, Inc. (CFLT), reported transactions on December 10, 2025, involving the company's equity securities.
- The transactions were executed pursuant to a Rule 10b5-1 plan established on March 13, 2025.
- Henry exercised stock options to acquire 62,500 shares of Class B Common Stock at an exercise price of $19.95 per share.
- Concurrently, 62,500 shares of Class B Common Stock were converted into an equal number of Class A Common Stock.
- Following the conversion, 62,500 shares of Class A Common Stock were sold at prices ranging from $30.00 to $30.005 per share.
- After these reported transactions, Henry beneficially owns 28,549 shares of Class A Common Stock and 187,500 shares of Class B Common Stock (held as stock options).
Sentiment
Score: 5
Explanation: The sentiment is neutral. While it involves insider selling, the transaction was pre-planned under a 10b5-1 plan, which typically indicates a routine liquidity event rather than a reaction to new, negative company-specific information. The insider also realized a profit from the option exercise.
Positives
- The exercise of stock options at $19.95 and subsequent sale at approximately $30.00 indicates a profitable transaction for the insider, realizing value from their equity compensation.
- The transaction was conducted under a pre-arranged 10b5-1 plan, which suggests a planned liquidity event rather than a reaction to new, undisclosed negative information.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a neutral to slightly negative signal regarding the company's near-term prospects or valuation.
Risks
- No specific risks are mentioned in this transactional filing. The general market perception of insider selling could potentially impact investor sentiment.
Future Outlook
This Form 4 filing reports past transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing is a routine insider transaction report and does not provide specific industry context. Insider transactions are common across all industries as executives and directors manage their personal portfolios and liquidity.
Stakeholder Impact
- Shareholders: May observe the insider sale and consider its implications for market sentiment, although the pre-arranged 10b5-1 plan mitigates concerns that the sale is based on new, undisclosed negative information.
Key Dates
| Date | Description |
|---|---|
| 03/13/2025 | Date the Rule 10b5-1 plan was established. |
| 12/10/2025 | Date of the reported transactions (stock option exercise, conversion, and sale of shares). |
| 12/12/2025 | Date the Form 4 filing was signed. |
| 05/02/2031 | Expiration date of the exercised stock options. |
Keywords
Confluent, CFLT, Insider Trading, Form 4, Stock Sale, Director, Equity Compensation, 10b5-1 Plan, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.